Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate

Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.